Safety Assessment of Sorbitan Esters as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 17 9 2019
pubmed: 17 9 2019
medline: 20 3 2020
Statut: ppublish

Résumé

The Cosmetic Ingredient Review Expert Panel (Panel) assessed the safety of 20 sorbitan esters; this report included sorbitan esters that were reviewed in 1985 and 2002, as well as 3 previously unreviewed sorbitan esters (sorbitan undecylenate, sorbitan sesquicaprylate, and sorbitan palmate). Most of the sorbitan esters are reported to function in cosmetics as surfactant-emulsifying agents. The Panel reviewed the data from previous sorbitan ester reports, as well as additional data included in this report, to determine the safety of these ingredients. The Panel concluded that the sorbitan esters included in this safety assessment are safe in cosmetics in the present practices of use and concentration.

Identifiants

pubmed: 31522651
doi: 10.1177/1091581819871877
doi:

Substances chimiques

Cosmetics 0
Esters 0
Polysorbates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

60S-80S

Auteurs

Monice M Fiume (MM)

Cosmetic Ingredient Review Senior Director, Cosmetic Ingredient Review, Washington, DC, USA.

Wilma F Bergfeld (WF)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Donald V Belsito (DV)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Ronald A Hill (RA)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Curtis D Klaassen (CD)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Daniel C Liebler (DC)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

James G Marks (JG)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Ronald C Shank (RC)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Thomas J Slaga (TJ)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Paul W Snyder (PW)

Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Lillian J Gill (LJ)

Cosmetic Ingredient Review Former Director, Washington, DC, USA.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH